Insmed Inc (NAS:INSM)
$ 69.61 -1.06 (-1.5%) Market Cap: 12.45 Bil Enterprise Value: 12.18 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 67/100

Q4 2022 Insmed Inc Earnings Call Transcript

Feb 23, 2023 / 01:30PM GMT
Release Date Price: $20.37 (-2.49%)
Operator

Hello, everyone, and welcome to the Insmed Fourth Quarter and Full Year 2022 Financial Results. My name is Nadia, and I'll be coordinating the call today. (Operator Instructions)

I will now hand over to your host, Eleanor Barisser, Investor Relations. To begin, Eleanor, Please go ahead.

Eleanor Barisser
Insmed Incorporated - Associate Director of IR

Thank you, Nadia. Good morning, and welcome to today's conference call to discuss our fourth quarter and full year financial results for 2022 and provide a business update. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Such statements represent our judgment as of today and may involve risks and uncertainties that may cause actual results to differ materially from the results discussed in the forward-looking statements. Please refer to our filings with the Securities and Exchange Commission, which are available through the SEC's website at www.sec.gov or from our website

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot